Trial · NCT02017444
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cardiovascular | Cardiac disorders | Placebo | 1 | 14 | |
| other | Cardiovascular | Cardiac disorders | AZD4017 (11b-HSD1 Inhibitor) | 1 | 17 | |
| other | Respiratory | Respiratory, thoracic and mediastinal disorders | Placebo | 3 | 14 | |
| other | Respiratory | Respiratory, thoracic and mediastinal disorders | AZD4017 (11b-HSD1 Inhibitor) | 4 | 17 | |
| other | Gastro-intestinal | Gastrointestinal disorders | Placebo | 3 | 14 | |
| other | Gastro-intestinal | Gastrointestinal disorders | AZD4017 (11b-HSD1 Inhibitor) | 8 | 17 | |
| other | Genito-urinary | General disorders | Placebo | 0 | 14 | |
| other | Genito-urinary | General disorders | AZD4017 (11b-HSD1 Inhibitor) | 6 | 17 | |
| other | Endocrine | Endocrine disorders | Placebo | 1 | 14 | |
| other | Endocrine | Endocrine disorders | AZD4017 (11b-HSD1 Inhibitor) | 1 | 17 | |
| other | Musculoskeletal | Musculoskeletal and connective tissue disorders | Placebo | 7 | 14 | |
| other | Musculoskeletal | Musculoskeletal and connective tissue disorders | AZD4017 (11b-HSD1 Inhibitor) | 6 | 17 | |
| other | Neoplasia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 14 | |
| other | Neoplasia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD4017 (11b-HSD1 Inhibitor) | 0 | 17 | |
| other | Neurological | Nervous system disorders | Placebo | 3 | 14 | |
| other | Neurological | Nervous system disorders | AZD4017 (11b-HSD1 Inhibitor) | 7 | 17 | |
| other | Psychological | Psychiatric disorders | Placebo | 4 | 14 | |
| other | Psychological | Psychiatric disorders | AZD4017 (11b-HSD1 Inhibitor) | 4 | 17 | |
| other | Immunological | Immune system disorders | Placebo | 1 | 14 | |
| other | Immunological | Immune system disorders | AZD4017 (11b-HSD1 Inhibitor) | 0 | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02017444/events